Related Experiment Video
Updated: Mar 18, 2026

03:20
Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
Published on: September 22, 2023
2.5K
Managing Constipation and Its Risks in Parkinson's Disease: Is There a Role for Dietary Fiber?
Matthew P Beke1, Wendy J Dahl1
1Department of Food Science and Human Nutrition, University of Florida, Gainesville, FL.
Summary
High-fiber diets may help Parkinson
Area of Science:
- Neuroscience
- Gastroenterology
- Nutritional Science
Background:
- Constipation is a common and quality-of-life-reducing consequence of Parkinson's disease (PD).
- PD-associated constipation links to gut dysbiosis and inflammatory metabolites, potentially worsening disease progression.
- Dietary interventions, including high-fiber diets and supplements, are considered for constipation management in PD.
Purpose of the Study:
- To evaluate the efficacy, safety, and feasibility of high-fiber diets and fiber supplements for managing constipation in people with Parkinson's disease.
Main Methods:
- This perspective reviews existing literature on fiber intake, gut microbiota, and constipation in Parkinson's disease.
- It analyzes the potential benefits and risks of various fiber sources and supplemental fiber for PD patients.
Main Results:
- Plant-based dietary patterns rich in diverse fibers may balance gut microbiota and metabolite production.
- Supplemental fiber may alleviate constipation but carries risks like appetite suppression and weight loss in neurodegeneration.
- Resistant fibers (bran, hull) may be most effective for stool bulking in PD-related slow transit and defecatory disorders.
Conclusions:
- High-fiber intake, particularly from diverse plant sources or specific resistant fibers, shows promise for PD constipation.
- Careful consideration of safety, including nutritional status, is crucial with fiber supplementation in PD.
- Further clinical trials are necessary to confirm the efficacy and optimal dosing of fiber interventions in Parkinson's disease.
Keywords:
Maladie de ParkinsonParkinson’s diseaseconstipationdietary fiberfibres alimentairesintestinal transit timemicrobiotamicrobiotesupplementationsupplémentationtemps de transit intestinalMore Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
1.0K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Drugs for Treatment of Constipation-Predominant IBS
1.1K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.1K
Irritable Bowel Syndrome III: Medical and Nursing Management
961
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
961
Drugs Affecting GI Tract Motility: Other Laxatives
1.3K
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
1.3K

